Moody’s revises Palomar Health’s outlook to stable

Moody’s Investors Service has revised Escondido, Calif.-based Palomar Health’s outlook to stable and affirmed the “Ba1” rating on its bonds, affecting $561 million of debt.

Advertisement

The rating revision and affirmation are based on a number of factors, including Palomar’s improved operating performance and balance sheet measures.

Palomar Health also faces several challenges, including the need to further improve its operating performance.

More articles on healthcare finance:
Tennessee hospital closes today, leaving 125 without jobs
Mount Sinai Beth Israel plans downsizing as losses mount
5 must-reads for hospital CFOs

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.